Teva effect on NBIX
I wonder what effect Teva's approval/non-approval on its drug will have on NBIX's stock price. If Teva's drug is approved, is that favorable for saying that NBIX will likely be approved too or will it be considered bad because of potential competition? If Teva's drug is not approved, will that make people worried about NBIX's drug not being approved or will it be a positive (their loss our gain). If Teva gets a black box label, is that good for us that they are limited or will it make people worried we get one too? You could view them all negative or positive I think. I don't claim to know the answer. Any thoughts on these scenarios?